Avinger, Inc. Share Price

Equities

AVGR

US0537348775

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 21:30:01 03/05/2024 BST 5-day change 1st Jan Change
3.9 USD +1.56% Intraday chart for Avinger, Inc. -0.76% +43.91%
Sales 2024 * 10.5M 837M Sales 2025 * 13.93M 1.11B Capitalization 6.19M 493M
Net income 2024 * -16M -1.28B Net income 2025 * -14M -1.12B EV / Sales 2024 * 0.59 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.44 x
P/E ratio 2024 *
-1.88 x
P/E ratio 2025 *
-2.89 x
Employees 70
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.56%
1 week-0.76%
Current month+4.28%
1 month+26.21%
3 months+50.00%
6 months+3.72%
Current year+43.91%
More quotes
1 week
3.54
Extreme 3.54
3.91
1 month
3.21
Extreme 3.21
4.37
Current year
2.50
Extreme 2.5
5.45
1 year
2.50
Extreme 2.5
18.00
3 years
2.50
Extreme 2.5
438.00
5 years
2.50
Extreme 2.5
2 340.00
10 years
2.50
Extreme 2.5
1 000 000.00
More quotes
Managers TitleAgeSince
Founder 63 07/03/07
Chief Executive Officer 61 28/12/14
Director of Finance/CFO 41 31/12/19
Members of the board TitleAgeSince
Chief Executive Officer 61 28/12/14
Chairman 81 30/11/14
Director/Board Member 72 28/02/11
More insiders
Date Price Change Volume
03/05/24 3.9 +1.56% 9,361
02/05/24 3.84 +4.34% 4,837
01/05/24 3.68 -1.60% 3,866
30/04/24 3.74 -0.80% 6,576
29/04/24 3.77 +1.07% 1,373

Delayed Quote Nasdaq, May 03, 2024 at 09:30 pm

More quotes
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.9 USD
Average target price
5 USD
Spread / Average Target
+28.21%
Consensus